BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2825968)

  • 21. Changes in the patterns of protein phosphorylation associated with granulocytic and monocytic-induced differentiation of HL-60 cells.
    Faille A; Poirier O; Turmel P; Chomienne C; Charron DJ; Abita JP
    Anticancer Res; 1986; 6(5):1053-63. PubMed ID: 3467646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
    Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
    Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
    Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein.
    Constantinou A; Kiguchi K; Huberman E
    Cancer Res; 1990 May; 50(9):2618-24. PubMed ID: 2158395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinoic acid-induced RB (retinoblastoma) hypophosphorylation enhanced by CGP 52411 (4,5-dianilinophthalimide), an EGF family tyrosine kinase receptor inhibitor.
    Yen A; Soong S
    Eur J Cell Biol; 1996 Apr; 69(4):327-34. PubMed ID: 8741214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
    Chapekar MS; Hartman KD; Knode MC; Glazer RI
    Mol Pharmacol; 1987 Feb; 31(2):140-5. PubMed ID: 3100942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of commitment of human leukemia HL-60 cells to terminal granulocytic maturation.
    Tsiftsoglou AS; Wong W; Hyman R; Minden M; Robinson SH
    Cancer Res; 1985 May; 45(5):2334-9. PubMed ID: 3857118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
    Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A decrease in the intracellular guanosine 5'-triphosphate concentration is necessary for granulocytic differentiation of HL-60 cells, but growth cessation and differentiation are not associated with a change in the activation state of Ras, the transforming principle of HL-60 cells.
    Pilz RB; Huvar I; Scheele JS; Van den Berghe G; Boss GR
    Cell Growth Differ; 1997 Jan; 8(1):53-9. PubMed ID: 8993834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
    Cheng HW; Armstrong RD; Sadée W
    Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the catalytic and regulatory subunits of protein phosphatase type 2A may be differentially modulated during retinoic acid-induced granulocytic differentiation of HL-60 cells.
    Nishikawa M; Omay SB; Toyoda H; Tawara I; Shima H; Nagao M; Hemmings BA; Mumby MC; Deguchi K
    Cancer Res; 1994 Sep; 54(18):4879-84. PubMed ID: 8069853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple mechanisms for the inhibition of rRNA synthesis during HL-60 leukemia cell differentiation.
    Schwartz EL; Nilson L
    J Cell Physiol; 1988 Sep; 136(3):526-30. PubMed ID: 3170648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of sterol and phospholipid synthesis in HL-60 promyelocytic leukemia cells by inducers of myeloid differentiation.
    Cooper RA; Ip SH; Cassileth PA; Kuo AL
    Cancer Res; 1981 May; 41(5):1847-52. PubMed ID: 6938303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of phosphotyrosine-containing proteins during differentiation of chicken erythroleukemia cells (HD3).
    Grdisa M
    Cell Biochem Funct; 1998 Dec; 16(4):277-82. PubMed ID: 9857490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered regulation of c-myc in an HL-60 differentiation resistant subclone, HL-60-1E3.
    Ely CM; Leftwich JA; Chenevix-Trench G; Hall RE; Westin EH
    Cancer Res; 1987 Sep; 47(17):4595-600. PubMed ID: 3476196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of transferrin receptor in myeloid and monocytic differentiation of HL-60 leukemia cells.
    Ho PT; Ishiguro K; Sartorelli AC
    Cancer Res; 1989 Apr; 49(8):1989-95. PubMed ID: 2702640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycosyltransferase alterations are cell type related when human promyelocytic leukemia (HL-60) cells are treated with various inducers of differentiation.
    Liu CK; Schmied R; Schreiber C; Rosen A; Qian GX; Waxman S
    Exp Hematol; 1983 Sep; 11(8):738-46. PubMed ID: 6414838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
    Bhalla K; Hindenburg A; Taub RN; Grant S
    Cancer Res; 1985 Aug; 45(8):3657-62. PubMed ID: 3860286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
    Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S
    Cancer Res; 1989 Jan; 49(2):331-4. PubMed ID: 2910452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.